Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -3.50 | N/A |
PEG Ratio (TTM) | 0.11 | N/A |
P/S Ratio (TTM) | 0.34 | N/A |
P/B Ratio (TTM) | 1.13 | N/A |
P/FCF Ratio (TTM) | -10.18 | N/A |
Price to 5YR AVG Earnings Ratio | -5.32 | N/A |
Price to 5YR AVG FCF Ratio | -5.21 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -17.12% | N/A |
ROE (TTM) | -29.55% | N/A |
Net Profit Margin (TTM) | -9.79% | N/A |
ROIC 5YR AVG | -72.70% | N/A |
Growth (22%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -33.45% | -1,182.39% | -723.02% |
Revenue | 3.57% | 26.08% | 17.61% |
Net Income | -32.95% | -1,193.65% | -730.20% |
Cash Flow | -80.46% | -251.84% | -208.70% |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.24 | N/A |
Quick Ratio (TTM) | 1.60 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 1.70 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | 0.00% | N/A |